CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Renata Limited Company Snapshot
Renata Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Renata Limited with three other pharmaceutical manufacturers in Asia: Seikagaku Corporation of JAPAN (2019 sales of 28.38 billion Japanese Yen [US$268.80 million] of which 77% was Pharmaceutical Products), Beximco Pharmaceuticals Limited (22.82 billion Bangladeshi Taka [US$269.24 million] ), and Daewon Pharmaceutical Co Ltd which is based in KOREA (SOUTH) (317.83 billion Korean Won [US$270.15 million] of which 99% was Phamaceutical).

Sales Analysis. Renata Limited reported sales of 22.81 billion Bangladeshi Taka (US$269.15 million) for the fiscal year ending June of 2019. This represents an increase of 19.7% versus 2018, when the company's sales were 19.05 billion Bangladeshi Taka. Sales at Renata Limited have increased during each of the previous five years (and since 2014, sales have increased a total of 100%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Renata Limited
  Stock Performance Chart for Renata Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2020): 1,164.40
(Figures in Bangladeshi Taka)
1 Week -1.9%   13 Weeks -1.6%  
4 Weeks 13.5%   52 Weeks 0.9%  
 
Renata Limited Key Data:
  Ticker: RENATA Country: BANGLADESH
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 22,809,301,672
(Year Ending Jan 2020).
Employees: 7,324
  Currency: Bangladeshi Taka Market Cap: 103,153,314,549
  Fiscal Yr Ends: June Shares Outstanding: 88,589,243
  Share Type: Ordinary Closely Held Shares: N/A
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.